403 related articles for article (PubMed ID: 28241318)
1. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
Hackett SF; Seidel C; Abraham S; Chadha R; Fortmann SD; Campochiaro PA; Cooke JP
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1296-1303. PubMed ID: 28241318
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
3. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
4. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
Pan X; Lv Y
Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Delivery of VEGF-A
Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
7. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
8. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
9. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
10. Functional analyses of TNFR2 in physiological and pathological retina angiogenesis.
Wan T; Xu Z; Zhou HJ; Zhang H; Luo Y; Li Y; Min W
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):211-21. PubMed ID: 23188724
[TBL] [Abstract][Full Text] [Related]
11. Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.
Liu N; Sun Y; Zhao N; Chen L
Int J Clin Exp Pathol; 2014; 7(10):6814-9. PubMed ID: 25400763
[TBL] [Abstract][Full Text] [Related]
12. Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy.
Patel C; Narayanan SP; Zhang W; Xu Z; Sukumari-Ramesh S; Dhandapani KM; Caldwell RW; Caldwell RB
Am J Pathol; 2014 Nov; 184(11):3040-51. PubMed ID: 25203536
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Liu N; Chen L; Cai N
Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
[TBL] [Abstract][Full Text] [Related]
14. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
[TBL] [Abstract][Full Text] [Related]
15. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
[TBL] [Abstract][Full Text] [Related]
16. PERK Inhibition Suppresses Neovascularization and Protects Neurons During Ischemia-Induced Retinopathy.
Shi S; Ding C; Zhu S; Xia F; Buscho SE; Li S; Motamedi M; Liu H; Zhang W
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):17. PubMed ID: 37566408
[TBL] [Abstract][Full Text] [Related]
17. Macrophages promote vasculogenesis of retinal neovascularization in an oxygen-induced retinopathy model in mice.
Gao X; Wang YS; Li XQ; Hou HY; Su JB; Yao LB; Zhang J
Cell Tissue Res; 2016 Jun; 364(3):599-610. PubMed ID: 26841878
[TBL] [Abstract][Full Text] [Related]
18. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
19. Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.
Shaw LC; Li Calzi S; Li N; Moldovan L; Sengupta-Caballero N; Quigley JL; Ivan M; Jun B; Bazan NG; Boulton ME; Busik J; Neu J; Grant MB
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):858-869. PubMed ID: 29490339
[TBL] [Abstract][Full Text] [Related]
20. Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model.
Yang L; Xu Y; Li W; Yang B; Yu S; Zhou H; Yang C; Xu F; Wang J; Gao Y; Huang Y; Lu L; Liang X
J Mol Neurosci; 2015 May; 56(1):78-88. PubMed ID: 25451596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
